Loading...

In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection

We have shown in a murine model system for cytomegalovirus (CMV) disease in the immunocompromised host that in vivo application of recombinant human IL-2 (rhIL-2) can enhance the antiviral effect of a limited number of CD8+T lymphocytes, not only in prophylaxis, but also in therapy, when virus has a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Format: Artigo
Sprog:Inglês
Udgivet: The Rockefeller University Press 1987
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2188275/
https://ncbi.nlm.nih.gov/pubmed/3029272
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!